Literature DB >> 27584730

Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Dirk P Dittmer, Blossom Damania.   

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. This human gammaherpesvirus was discovered in 1994 by Drs. Yuan Chang and Patrick Moore. Today, there are over five thousand publications on KSHV and its associated malignancies. In this article, we review recent and ongoing developments in the KSHV field, including molecular mechanisms of KSHV pathogenesis, clinical aspects of KSHV-associated diseases, and current treatments for cancers associated with this virus.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27584730      PMCID： PMC5004954          DOI： 10.1172/JCI84418

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  200 in total

1.  The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.

Authors:  Jeffrey S Scehnet; Eric J Ley; Valery Krasnoperov; Ren Liu; Parmeet K Manchanda; Eric Sjoberg; Anna P Kostecke; Sachin Gupta; S Ram Kumar; Parkash S Gill
Journal:  Blood       Date:  2008-10-03       Impact factor: 22.113

2.  An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.

Authors:  Alka Prasad; Michael Lu; David M Lukac; Steven L Zeichner
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.

Authors:  Amy Lingel; Erica Ehlers; Qianli Wang; Mingxia Cao; Charles Wood; Rongtuan Lin; Luwen Zhang
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.

Authors:  Sam Mbulaiteye; Vickie Marshall; Rachel K Bagni; Cheng-Dian Wang; Georgina Mbisa; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Eric A Engels; Edward Katongole-Mbidde; Robert J Biggar; Denise Whitby
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

5.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

6.  Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.

Authors:  Susan E Krown; Margaret Z Borok; Thomas B Campbell; Corey Casper; Dirk P Dittmer; Mina C Hosseinipour; Ronald T Mitsuyasu; Anisa Mosam; Jackson Orem; Warren T Phipps
Journal:  J Clin Oncol       Date:  2014-07-07       Impact factor: 44.544

7.  Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.

Authors:  Justin Stebbing; Dimitra Bourboulia; Margaret Johnson; Stephen Henderson; Ian Williams; Natalie Wilder; Mervyn Tyrer; Mike Youle; Nesrina Imami; Toru Kobu; Wolfgang Kuon; Joachim Sieper; Frances Gotch; Chris Boshoff
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.

Authors:  Soren Gantt; Ashok Cattamanchi; Elizabeth Krantz; Amalia Magaret; Stacy Selke; Steven R Kuntz; Meei-Li Huang; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Clin Virol       Date:  2014-03-13       Impact factor: 3.168

9.  Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.

Authors:  Ling Wang; Blossom Damania
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

10.  Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.

Authors:  Myung-Shin Lee; Tiffany Jones; Dae-Yong Song; Jae-Hyuk Jang; Jae U Jung; Shou-Jiang Gao
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823
View more
  77 in total

1.  A case of recipient-derived pulmonary Kaposi sarcoma after bilateral lung transplantation.

Authors:  Julie Ng; Allison Cleary; Hisashi Tsukada; Hilary Goldberg
Journal:  J Heart Lung Transplant       Date:  2018-06       Impact factor: 10.247

2.  Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.

Authors:  Ryota Nakayama; Yumiko Ueno; Keiji Ueda; Tomoyuki Honda
Journal:  Oncogene       Date:  2019-02-15       Impact factor: 9.867

3.  Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.

Authors:  Jason P Wong; Timothy J Stuhlmiller; Louise C Giffin; Carolina Lin; Rachele Bigi; Jichen Zhao; Weihe Zhang; Ariana G Bravo Cruz; Steven I Park; H Shelton Earp; Dirk P Dittmer; Stephen V Frye; Xiaodong Wang; Gary L Johnson; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.

Authors:  Sang-Hoon Sin; Anthony B Eason; Rachele Bigi; Yongbaek Kim; SunAh Kang; Kelly Tan; Tischan A Seltzer; Raman Venkataramanan; Hyowon An; Dirk P Dittmer
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Deboeeta Chatterjee; Edward A Berger
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 6.  Innate Sensing of DNA Virus Genomes.

Authors:  Zhe Ma; Guoxin Ni; Blossom Damania
Journal:  Annu Rev Virol       Date:  2018-09-29       Impact factor: 10.431

7.  Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.

Authors:  Jedediah Seltzer; Razia Moorad; Jason M Schifano; Justin T Landis; Dirk P Dittmer
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

8.  Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.

Authors:  Dirk P Dittmer; Kristen Tamburro; Huichao Chen; Anthony Lee; Marcia K Sanders; Tischan A Wade; Sonia Napravnik; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Caroline H Shiboski; Judith A Aberg
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 9.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

10.  Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; John R Ngowi; Yasaman Mortazavi; Eun Hee Kwon; Danielle M Shea; Veenu Minhas; Julius Mwaiselage; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.